Update on acute liver failure

Current Opinion in Critical Care

Volumn 21, Issue 2, 2015, Pages 134-141

  Singanayagam, Arjuna ^a   Bernal, William ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

acetaminophen; acute liver failure; artificial liver support; autoimmune; coagulopathy

Indexed keywords

ACUTE LIVER FAILURE; ARTIFICIAL SUPPPORT DEVICE; ARTIFICIAL VENTILATION; BLEEDING; HUMAN; INFECTION SENSITIVITY; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; LIFE SUPPORT EQUIPMENT; LIVER REGENERATION; LIVER TRANSPLANTATION; MAINTENANCE OF RESPIRATION AND CIRCULATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; THERAPEUTIC HYPERVENTILATION; COMPLICATION; HEPATITIS, AUTOIMMUNE; LIVER FAILURE, ACUTE; MORTALITY; PROCEDURES;

CORTICOSTEROID; PARACETAMOL;

ACETAMINOPHEN; ADRENAL CORTEX HORMONES; CRITICAL CARE; HEPATITIS, AUTOIMMUNE; HUMANS; INTRACRANIAL HYPERTENSION; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION;

EID: 84926303788     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000187     Document Type: Review

References (69)

1. Polson J, Lee WM; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41:1179-1197
2. Bernal W, Wendon J. Acute liver failure. N Engl J Med 2013; 369:2525-2534
3. Bernal W, Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol 2013; 59:74-80
4. EscorsellA, Mas A, la Mata de M; Spanish Group for the Study of Acute Liver Failure. Acute liver failure in Spain: analysis of 267 cases. Liver Transpl 2007; 13:1389-1395
5. Bower WA, Johns M, Margolis HS, et al. Population-based surveillance for acute liver failure. Am J Gastroenterol 2007; 102:2459-2463
6. Bretherick AD, Craig DGN, Masterton G, et al. Acute liver failure in Scotland between 1992 and 2009; incidence, aetiology and outcome. QJM 2011; 104:945-956
7. Devlin J, OGrady J. Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology. Gut 1999; 45 (Suppl 6):VI1-VI22
8. Neuberger J, Gimson A, Davies M, et al. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 2008; 57:252-257
9. Hawton K, Bergen H, Simkin S, et al. Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: interrupted time series analyses. BMJ 2013; 346:f403
10. ORiordan A, Brummell Z, Sizer E, et al. Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity. Nephrol Dial Transplant 2011; 26:3501-3508
11. Fontana RJ, Ellerbe C, Durkalski VE, et al. Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study. Liver Int 2015; 35:370-380
12. OGrady J. Timing and benefit of liver transplantation in acute liver failure. J Hepatol 2014; 60:663-670
13. McGill MR, Staggs VS, Sharpe MR, et al. Serum mitochondrial biomarkers and damage-Associated molecular patterns are higher in acetaminophen overdose patients with poor outcome. Hepatology 2014; 60:1336-1345
14. Woolbright BL, McGill MR, Staggs VS, et al. Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients. Toxicol Sci 2014; 142:436-444
15. Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 1991; 303:1026-1029
16. Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-Acetylcysteine improves transplant-free survival in early stage nonacetaminophen acute liver failure. Gastroenterology 2009; 137:856-864
17. Bjornsson E, Olsson R. Outcome and prognostic markers in severe druginduced liver disease. Hepatology 2005; 42:481-489
18. Karkhanis J, Verna EC, Chang MS, et al. Steroid use in acute liver failure. Hepatology 2014; 59:612-621
19. Seetharam A, Perrillo R, Gish R. Immunosuppression in patients with chronic hepatitis B. Curr Hepatol Rep 2014; 13:235-244
20. Dao DY, Seremba E, Ajmera V, et al. Use of nucleoside (tide) analogues in patients with hepatitis B-related acute liver failure. Dig Dis Sci 2012; 57:1349-1357
21. Westbrook RH, Yeoman AD, Joshi D, et al. Outcomes of severe pregnancyrelated liver disease: refining the role of transplantation. Am J Transplant 2010; 10:2520-2526
22. Joshi D, James A, Quaglia A, et al. Liver disease in pregnancy. Lancet 2010; 375:594-605
23. European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilsons disease. J Hepatol 2012; 56:671-685
24. Horton JD, San Miguel FL, Membreno F, et al. Budd-Chiari syndrome: illustrated review of current management. Liver Int 2008; 28:455-466
25. Henrion J. Hypoxic hepatitis. Liver Int 2012; 32:1039-1052
26. Raurich JM, Llompart-Pou JA, Ferreruela M, et al. Hypoxic hepatitis in critically ill patients: incidence, etiology and risk factors for mortality. J Anesth 2011; 25:50-56
27. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137:947-954
28. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010; 376:190-201
29. Mller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J 2013; 34:2804-2811
30. Siniscalchi A, Dante A, Spedicato S, et al. Hyperdynamic circulation in acute liver failure: reperfusion syndrome and outcome following liver transplantation. Transplant Proc 2010; 42:1197-1199
31. Shawcross DL, Davies NA, Mookerjee RP, et al. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology 2004; 39:471-475
32. Eefsen M, Dethloff T, Frederiksen H-J, et al. Comparison of terlipressin and noradrenaline on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure 14 in need of inotropic support. J Hepatol 2007; 47:381-386
33. Harry R, Auzinger G, Wendon J. The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology 2002; 36:395-402
34. Parekh NK, Hynan LS, De Lemos J, Lee WM; Acute Liver Failure Study Group. Elevated troponin I levels in acute liver failure: is myocardial injury an integral part of acute liver failure? Hepatology 2007; 45:1489-1495
35. Audimooolam VK, McPhail MJ, Sherwood R, et al. Elevated troponin I and its prognostic significance in acute liver failure. Crit Care 2012; 16:R228
36. Baudouin SV, Howdle P, OGrady JG, Webster NR. Acute lung injury in fulminant hepatic failure following paracetamol poisoning. Thorax 1995; 50:399-402
37. Wang D-W, Yin Y-M, Yao Y-M. AdVances in the management of acute liver failure. WJG 2013; 19:7069-7077
38. Audimoolam VK, McPhail MJW, Wendon JA, et al. Lung injury and its prognostic significance in acute liver failure. Crit Care Med 2014; 42:592-600
39. Brower RG, Rubenfeld GD. Lung-protective ventilation strategies in acute lung injury. Crit Care Med 2003; 31 (4 Suppl):S312-S316
40. Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with nonparacetamol-induced acute liver failure. Gut 2009; 58:443-449
41. Tujios SR, Hynan LS, Vazquez MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol 2014. [Epub ahead of print]
42. Larsen FS, Wendon J. Brain edema in liver failure: basic physiologic principles and management. Liver Transpl 2002; 8:983-989
43. Oketani M, Ido A, Nakayama N, et al. Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: summary of the annual nationwide survey between 2004 and 2009. Hepatol Res 2013; 43:97-105
44. Bernal W, Hall C, Karvellas CJ, et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007; 46:1844-1852
45. Ott P, Vilstrup H. Cerebral effects of ammonia in liver disease: current hypotheses. Metab Brain Dis 2014; 29:901-911
46. Shawcross DL, Wendon JA. The neurological manifestations of acute liver failure. Neurochem Int 2012; 60:662-671
47. Wijdicks EFME, Nyberg SLS. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc 2002; 34:1220-1222
48. Sidi A, Mahla ME. Noninvasive monitoring of cerebral perfusion by transcranial Doppler during fulminant hepatic failure and liver transplantation. Anesth Analg 1995; 80:194-200
49. Karvellas CJ, Fix OK, Battenhouse H, et al. Outcomes and complications of intracranial pressure monitoring in acute liver failure. Crit Care Med 2014; 42:1157-1167
50. Slack AJ, Auzinger G, Willars C, et al. Ammonia clearance with haemofiltration in adults with liver disease. Liver Int 2014; 34:42-48
51. Acharya SK, Bhatia V, Sreenivas V, et al. Efficacy of L-ornithine L-Aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology 2009; 136:2159-2168
52. Murphy N, Auzinger G, Bernal W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004; 39:464-470
53. Canalese J, Gimson AE, Davis C, et al. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 1982; 23:625-629
54. Jalan RO, Damink SW, Deutz NE, et al. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999; 354:1164-1168
55. Rose C, Michalak A, Pannunzio M, et al. Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure. Hepatology 2000; 31:872-877
56. Larsen FS, Murphy N, Bernal W, et al. The prophylactive effect of mild hypothermia to prevent brain edema in patients with acute liver failure: results of a multicenter randomized, controlled trial. J Hepatol 2011; 54:S26-S36
57. Strauss G, Hansen BA, Knudsen GM, Larsen FS. Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure. J Hepatol 1998; 28:199-203
58. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011; 365:147-156
59. Tripodi A, Salerno F, Chantarangkul V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005; 41:553-558
60. Habib M, Roberts LN, Patel RK, et al. Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation. Liver Int 2014; 34:672-678
61. Agarwal B, Wright G, Gatt A, et al. Evaluation of coagulation abnormalities in acute liver failure. J Hepatol 2012; 57:780-786
62. Rolando N, Harvey F, Brahm J, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990; 11:49-53
63. Rolando N, Harvey F, Brahm J, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol 1991; 12:1-9
64. Bernsmeier C, Antoniades CG, Wendon J. Whats new in acute liver failure? Intensive Care Med 2014; 40:1545-1548
65. Antoniades CG, Berry PA, Wendon JA, Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 2008; 49:845-861
66. Possamai LA, Thursz MR, Wendon JA, Antoniades CG. Modulation of monocyte/macrophage function: a therapeutic strategy in the treatment of acute liver failure. J Hepatol 2014; 61:439-445
67. Karvellas CJ, Cavazos J, Battenhouse H, et al. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol 2014; 12:1942-1949
68. Dharel N, Bajaj JS. Antibiotic prophylaxis in acute liver failure: friend or foe? Clin Gastroenterol Hepatol 2014; 12:1950-1952
69. Saliba F, Camus C, Durand F, et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med 2013; 159:522-531